Stock Earnings

Question 1

What are Luye Pharma Group Ltd's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Luye Pharma Group Ltd has a total asset of $29,612, Net profit of $471

Question 2

What are the key financial ratios for LYPHF?

Accepted Answer

Luye Pharma Group Ltd's Current ratio is 1.91, has a Net margin is 7.77, sales per share of $1.61.

Question 3

How is Luye Pharma Group Ltd's revenue broken down by segment or geography?

Accepted Answer

Luye Pharma Group Ltd largest revenue segment is Oncology Drugs, at a revenue of 2,260,206,730 in the most earnings release.For geography, China is the primary market for Luye Pharma Group Ltd, at a revenue of 5,339,391,733.

Question 4

Is Luye Pharma Group Ltd profitable?

Accepted Answer

yes, according to the latest financial statements, Luye Pharma Group Ltd has a net profit of $471

Question 5

Does Luye Pharma Group Ltd have any liabilities?

Accepted Answer

yes, Luye Pharma Group Ltd has liability of 15,457

Question 6

How many outstanding shares for Luye Pharma Group Ltd?

Accepted Answer

Luye Pharma Group Ltd has a total outstanding shares of 3,761.67

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	6,167	6,061	6,143	5,981	5,200	5,539
Revenue Growth (YoY)	-2%	-1%	3%	15%	-6%	-13%
Cost of Revenue	2,044	2,017	1,938	1,841	1,803	1,549
Gross Profit	4,123	4,044	4,204	4,140	3,396	3,990
Selling, General & Admin	2,592	2,398	2,700	2,402	2,270	2,180
Research & Development	--	498	586	857	683	789
Operating Expenses	2,720	2,725	3,170	3,223	2,961	2,801
Other Non Operating Income (Expenses)	--	--	--	--	--	-1
Pretax Income	766	839	700	669	-74	942
Income Tax Expense	202	194	161	86	70	238
Net Income	396	471	532	604	-134	706
Net Income Growth	-49%	-11%	-12%	-551%	-119%	-49%
Shares Outstanding (Diluted)	3,761.67	3,761.67	3,728.36	3,480.85	3,445.43	3,193.94
Shares Change (YoY)	0%	1%	7%	1%	8%	-1%
EPS (Diluted)	0.1	0.12	0.14	0.17	-0.03	0.22
EPS Growth	-48%	-12%	-18%	-545%	-118%	-49%
Free Cash Flow	766	-1,540	430	490	-1,359	-486
Free Cash Flow Per Share	0.2	-0.4	0.11	0.14	-0.39	-0.15
Gross Margin	66.85%	66.72%	68.43%	69.21%	65.3%	72.03%
Operating Margin	22.73%	21.74%	16.83%	15.31%	8.36%	21.46%
Profit Margin	6.42%	7.77%	8.66%	10.09%	-2.57%	12.74%
Free Cash Flow Margin	12.42%	-25.4%	6.99%	8.19%	-26.13%	-8.77%
EBITDA	2,252	2,108	1,735	1,587	439	1,193
EBITDA Margin	36.51%	34.77%	28.24%	26.53%	8.44%	21.53%
D&A For EBITDA	850	790	701	671	4	4
EBIT	1,402	1,318	1,034	916	435	1,189
EBIT Margin	22.73%	21.74%	16.83%	15.31%	8.36%	21.46%
Effective Tax Rate	26.37%	23.12%	23%	12.85%	-94.59%	25.26%

Luye Pharma Group Ltd (LYPHF) Price

LYPHF Stock Price Chart

LYPHF Income

Follow-Up Questions